TY  - CONF
AU  - Cvetkovski, A
AU  - Tasić, Ljiljana
AU  - Bettini, R
AU  - Giordano, F
PY  - 2003
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/471
PB  - Slovenian Pharmaceutical Society
C3  - Farmacevtski Vestnik
T1  - Influence of β cyclodextrin on the crystallinity and dissolution rate of carbamazepine polymorphs
VL  - 54
IS  - SPEC. ISS.
SP  - 379
EP  - 380
UR  - https://hdl.handle.net/21.15107/rcub_farfar_471
ER  - 

@conference{
author = "Cvetkovski, A and Tasić, Ljiljana and Bettini, R and Giordano, F",
year = "2003",
publisher = "Slovenian Pharmaceutical Society",
journal = "Farmacevtski Vestnik",
title = "Influence of β cyclodextrin on the crystallinity and dissolution rate of carbamazepine polymorphs",
volume = "54",
number = "SPEC. ISS.",
pages = "379-380",
url = "https://hdl.handle.net/21.15107/rcub_farfar_471"
}

Cvetkovski, A., Tasić, L., Bettini, R.,& Giordano, F.. (2003). Influence of β cyclodextrin on the crystallinity and dissolution rate of carbamazepine polymorphs. in Farmacevtski Vestnik
Slovenian Pharmaceutical Society., 54(SPEC. ISS.), 379-380.
https://hdl.handle.net/21.15107/rcub_farfar_471

Cvetkovski A, Tasić L, Bettini R, Giordano F. Influence of β cyclodextrin on the crystallinity and dissolution rate of carbamazepine polymorphs. in Farmacevtski Vestnik. 2003;54(SPEC. ISS.):379-380.
https://hdl.handle.net/21.15107/rcub_farfar_471 .

Cvetkovski, A, Tasić, Ljiljana, Bettini, R, Giordano, F, "Influence of β cyclodextrin on the crystallinity and dissolution rate of carbamazepine polymorphs" in Farmacevtski Vestnik, 54, no. SPEC. ISS. (2003):379-380,
https://hdl.handle.net/21.15107/rcub_farfar_471 .

TY  - CONF
AU  - Cvetkovski, A.
AU  - Tasić, Ljiljana
AU  - Stupar, Mirjana
PY  - 2002
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/369
PB  - Savez farmaceutskih udruženja Srbije, Beograd
C3  - Arhiv za farmaciju
T1  - Approach to choise and selection of methods for preformulation studies of solid dosage forms
T1  - Izbor i selekcija metoda za predformulaciona istraživanja čvrstih lekovitih oblika
VL  - 52
IS  - 4
SP  - 532
EP  - 533
UR  - https://hdl.handle.net/21.15107/rcub_farfar_369
ER  - 

@conference{
author = "Cvetkovski, A. and Tasić, Ljiljana and Stupar, Mirjana",
year = "2002",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Approach to choise and selection of methods for preformulation studies of solid dosage forms, Izbor i selekcija metoda za predformulaciona istraživanja čvrstih lekovitih oblika",
volume = "52",
number = "4",
pages = "532-533",
url = "https://hdl.handle.net/21.15107/rcub_farfar_369"
}

Cvetkovski, A., Tasić, L.,& Stupar, M.. (2002). Approach to choise and selection of methods for preformulation studies of solid dosage forms. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 52(4), 532-533.
https://hdl.handle.net/21.15107/rcub_farfar_369

Cvetkovski A, Tasić L, Stupar M. Approach to choise and selection of methods for preformulation studies of solid dosage forms. in Arhiv za farmaciju. 2002;52(4):532-533.
https://hdl.handle.net/21.15107/rcub_farfar_369 .

Cvetkovski, A., Tasić, Ljiljana, Stupar, Mirjana, "Approach to choise and selection of methods for preformulation studies of solid dosage forms" in Arhiv za farmaciju, 52, no. 4 (2002):532-533,
https://hdl.handle.net/21.15107/rcub_farfar_369 .